CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising genomic and enzymology research
4.1.2. The rise in research activities specifically in genomic research and disease diagnosis
4.1.3. Growth in health care expenditure
4.1.4. Increasing government initiatives and investments in R&D in molecular biology
4.1.5. Growing personalized healthcare treatment
4.2. Market Restraints & Challenges
4.2.1. Lack of skilled professionals in the transcriptonomics field
4.2.2. High competition in the market
4.2.3. Costly process
4.3. Market Opportunities
4.3.1. Emerging economies
CHAPTER 5 GLOBAL NUCLEIC ACID LABELING MARKET – BY PRODUCT
5.1. Reagents & Kits
5.1.1. Labels
5.1.1.1. Radioactive Labels
5.1.1.2. Non-Radioactive Labels
5.1.2. Probes
5.1.2.1. Radioactive Probes
5.1.2.2. Non-Radioactive
5.2. Services
CHAPTER 6 GLOBAL NUCLEIC ACID LABELING MARKET – BY LABELING
TECHNIQUE
6.1. Nick Translation
6.2. Random Primer
6.3. In Vitro Transcription
6.4. Reverse Transcription
6.5. End Labeling
CHAPTER 7 GLOBAL NUCLEIC ACID LABELING MARKET – BY APPLICATION
7.1. DNA Sequencing
7.2. Polymerase Chain Reaction
7.3. Fluorescence in Situ Hybridization
7.4. Microarrays
7.5. Blotting
7.6. in Situ Hybridization
CHAPTER 8 GLOBAL NUCLEIC ACID LABELING MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL NUCLEIC ACID LABELING MARKET - COMPANY
PROFILES
9.1. Enzo Biochem, Inc.
9.2. F. Hoffman-La Roche AG
9.3. Merck KgaA
9.4. General Electric Company
9.5. Agilent Technologies, Inc.
9.6. New England Biolabs
9.7. Vector Laboratories
9.8. Thermo Fisher Scientific, Inc.
9.9. Promega Corporation
9.10. Perkinelmer, Inc.
9.11. Qiagen N.V.
9.12. Active Motif, Inc.
9.13. Takara Bio USA, Inc.
9.14. Candor Bioscience GMBH
9.15. Innova Biosciences Ltd.
CHAPTER 10 GLOBAL NUCLEIC ACID LABELING MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
